NCT04721093 is a NA clinical trial of Photobiomodulation device in Regional Cerebral Blood Flow, sponsored by Pusan National University Yangsan Hospital.

Who is sponsoring NCT04721093?

NCT04721093 is sponsored by Pusan National University Yangsan Hospital.

What drugs are being tested in NCT04721093?

Interventions in NCT04721093: Photobiomodulation device.

What condition does NCT04721093 study?

NCT04721093 studies Regional Cerebral Blood Flow, Mild Cognitive Impairment, Cognitive Function.

Is NCT04721093 still recruiting?

NCT04721093 is currently completed. Last updated 22 January 2021.

Last reviewed 2021-01-22 · How we verify

NCT04721093

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Photobiomodulation on Changes in Cognitive Function and rCBF in MCI

Completed NA Last updated 22 January 2021

What this trial tests

NA trial testing Photobiomodulation device in Regional Cerebral Blood Flow in 14 participants. Completed in 30 June 2020.

Timeline

12 December 2019

Primary endpoint
30 April 2020

30 June 2020

Quick facts

Lead sponsor	Pusan National University Yangsan Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	12 December 2019
Primary completion	30 April 2020
Estimated completion	30 June 2020
Sites	1 location across South Korea

Drugs / interventions tested

Photobiomodulation device

Conditions studied

Regional Cerebral Blood Flow — all drugs for Regional Cerebral Blood Flow →
Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Cognitive Function — all drugs for Cognitive Function →

Sponsor

Pusan National University Yangsan Hospital

Who can join

55 and older, any sex, with Regional Cerebral Blood Flow or Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study has two goals. The first is to see if the cognitive improves when VA and CA are stimulated in MCI patients, and the second is to do an explanatory data analysis to see if that improves cognitive in relation to the rCBF improvement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Pusan National University Yangsan Hospital trials

Trials by the same sponsor.

NCT07511634 — Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Cont · NA · not yet recruiting
NCT07324226 — Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adul · NA · recruiting
NCT07334327 — Extracorporeal Blood Purification Using Oxiris for Septic Shock (EXPLORE Study) · NA · not yet recruiting
NCT07323823 — The Effect of PBM on the Electrical Activity of the Brain in Stroke Patients · NA · not yet recruiting
NCT07447271 — Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04721093 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pusan National University Yangsan Hospital
Last refreshed: 22 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04721093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing